![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 403/12 | (2006.01) |
C07D 401/04 | (2006.01) | ||
C07D 401/12 | (2006.01) | ||
C07D 235/30 | (2006.01) | ||
C07D 405/12 | (2006.01) | ||
C07D 403/14 | (2006.01) | ||
C07D 409/12 | (2006.01) | ||
A61K 31/498 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 239/84 | (2006.01) | ||
C07D 471/04 | (2006.01) | ||
C07D 475/00 | (2006.01) |
(11) | Number of the document | 3395814 |
(13) | Kind of document | T |
(96) | European patent application number | 18177131.2 |
Date of filing the European patent application | 2014-10-23 | |
(97) | Date of publication of the European application | 2018-10-31 |
(45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
(46) | Date of publication of the claims translation | 2022-07-25 |
(30) | Number | Date | Country code |
201361895472 P | 2013-10-25 | US | |
201461927782 P | 2014-01-15 | US |
(72) |
BIFULCO, Neil Jr. , US
DIPIETRO, Lucian V. , US
HODOUS, Brian L. , US
MIDUTURU, Chandrasekhar V. , US
|
(73) |
Blueprint Medicines Corporation ,
45 Sidney Street, Cambridge, MA 02139,
US
|
(74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Fibroblastų augimo faktoriaus receptoriaus inhibitoriai |
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR |
Payment date | Validity (years) | Amount | |
2024-09-23 | 11 | 289.00 EUR |
2025-10-23 |